血清L-ornithine衍生的聚氨酸作为帕金森病进展指标

Peter A LeWitt1, Jia Li2, Peggy Auinger3

  • 1Departments of Neurology and Pharmacology, and Sastry Foundation Endowed Chair in Parkinson Disease Research, Wayne State University School of Medicine, 4201 St. Antoine Street, UHC-8D, Detroit, MI, 48202, USA. aa1142@wayne.edu.

概括

帕金森病 (PD) 患者的L-ornithine衍生聚氨酸 (ODPA) 随着时间的推移而增加,特别是在血清中. 在某些PD亚型中,血清N-乙普特瑞辛的升高预测了疾病进展,这表明ODPA可能表明PD进展.